NRx Pharmaceuticals, Inc.NRXPNASDAQ

Revenue (LTM)

Net Income (LTM)

$-25M

+16.7% YoY

Free Cash Flow

$-11M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	-0	-0↓0.0%	-0↓100.0%	-0↓25.0%	-0↓0.0%
Operating Income	-22	-95↓331.5%	-44↑53.4%	-28↑37.8%	-20↑28.6%
Net Income	-52	-93↓79.7%	-40↑57.3%	-30↑24.2%	-25↑16.7%
EBITDA	-52	-93↓79.9%	-40↑57.3%	-30↑24.5%	-24↑19.9%
EPS Diluted	-1.51	-7.44↓392.7%	-0.60↑91.9%	-3.98↓563.3%	-2.39↑39.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	2	28↑1384.9%	20↓27.4%	5↓77.1%	1↓68.6%
Total Current Assets	3	33↑1016.5%	26↓21.1%	7↓73.3%	3↓52.0%
Total Assets	3	33↑1012.9%	26↓21.1%	7↓71.7%	4↓50.1%
Total Current Liabilities	46	12↓74.2%	16↑30.7%	19↑22.2%	22↑14.8%
Total Liabilities	47	12↓74.5%	18↑54.4%	19↑3.5%	27↑41.1%
Total Equity	-44	21↑147.5%	7↓64.4%	-12↓258.4%	-23↓97.9%
Total Debt	1	1↓35.0%	11↑1931.9%	9↓13.0%	7↓28.2%
Net Debt	-1	-27↓2450.6%	-10↑64.8%	5↑147.9%	5↑12.4%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-2	-38↓1564.6%	-40↓5.4%	-22↑45.5%	-11↑50.9%
Capital Expenditure	-0	-0↓250.0%	-0↓42.9%	-0↑70.0%	0
Free Cash Flow	-2	-38↓1563.4%	-40↓5.4%	-22↑45.5%	-11↑50.9%
Stock-Based Comp	1	8↑966.4%	4↓53.4%	0↓89.3%	0↑25.6%
Net Change in Cash	1	26↑2521.8%	-8↓129.3%	-15↓104.7%	-3↑79.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance